Novel personalized cancer vaccine platform based on Bacillus Calmette-Guèrin

BACKGROUND: Intratumoral BCG therapy, one of the earliest immunotherapies, can lead to infiltration of immune cells into a treated tumor. However, an increase in the number of BCG-induced tumor-specific T cells in the tumor microenvironment could lead to enhanced therapeutic effects. METHODS: Here,...

Descripción completa

Detalles Bibliográficos
Autores principales: Ylösmäki, Erkko, Fusciello, Manlio, Martins, Beatriz, Feola, Sara, Hamdan, Firas, Chiaro, Jacopo, Ylösmäki, Leena, Vaughan, Matthew J, Viitala, Tapani, Kulkarni, Prasad S, Cerullo, Vincenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Oncolytic and Local Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286790/
https://www.ncbi.nlm.nih.gov/pubmed/34266884
http://dx.doi.org/10.1136/jitc-2021-002707

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286790/
https://www.ncbi.nlm.nih.gov/pubmed/34266884
http://dx.doi.org/10.1136/jitc-2021-002707

Ejemplares similares